Loading…
Based on limited metadata, Results RNA, LLC received an FDA Warning Letter on April 6, 2018, regarding products classified as "Other" (specific product details are unavailable). Without access to the full letter text or subject line, the exact nature of the violations cannot be determined from the metadata provided. The warning was issued through an FDA office, though the specific issuing office is not identified in this summary. Further review of the complete Warning Letter would be necessary to identify the specific regulatory concerns and compliance issues cited.